InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Christensen Jamie, Directeur Scientifique. Officer active across 1 company, notably Mirati Therapeutics, Inc.. Aggregated, 25 filings have been logged. Split: 0 buy · 14 sells. Total volume traded: €1.3m. Activity tracked since 24 May 2021. The latest transaction was disclosed on 16 January 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations25 total
56,495 sharesCommon StockSEC:0001140361-24-003529:0
966 shares@ US$59.021.8% of flowCommon StockSEC:0001628280-24-001690:0
1,531 shares@ US$58.812.8% of flowCommon StockSEC:0001628280-24-000699:0
17,021 shares@ US$58.7530.8% of flowCommon StockSEC:0001628280-24-000288:0
2,387 shares@ US$57.504.3% of flowCommon StockSEC:0001628280-23-042001:0
2,388 shares@ US$35.632.7% of flowCommon StockSEC:0001628280-23-032116:0
22,297 shares@ US$37.0025.7% of flowCommon StockSEC:0001628280-23-028874:0
619 shares@ US$45.29050.9% of flowCommon StockSEC:0001628280-23-019629:0
26,864 shares0Common StockSEC:0001214659-23-001043:0
1,358 shares@ US$42.37781.8% of flowCommon StockSEC:0001214659-23-000809:0
1,949 shares@ US$46.602.9% of flowCommon StockSEC:0001214659-23-000289:0
2,410 shares@ US$42.99773.3% of flowCommon StockSEC:0001214659-22-015125:0
1,726 shares@ US$90.18935.0% of flowCommon StockSEC:0001214659-22-014531:0
19,149 shares0Common StockSEC:0001214659-22-011031:0
624 shares@ US$63.547.1% of flowCommon StockSEC:0001214659-22-008031:0
10,755 shares0Common StockSEC:0001214659-22-000857
10,755 shares0Common StockSEC:0001214659-22-000857:0
1,442 shares@ US$147.723577.4% of flowCommon StockSEC:0001214659-22-000418
1,442 shares@ US$147.723536.0% of flowCommon StockSEC:0001214659-22-000418:0
19,149 shares0Common StockSEC:0001214659-21-013377
19,149 shares0Common StockSEC:0001214659-21-013377:0
6,856 shares0Common StockSEC:0001214659-21-012820
6,856 shares0Common StockSEC:0001214659-21-012820:0
435 shares@ US$154.3410.5% of flowCommon StockSEC:0001214659-21-005911:0
435 shares@ US$154.3410.5% of flowCommon StockSEC:0001214659-21-005911
25 of 25 declarations
About Christensen Jamie
Jamie Christensen is the Executive Vice President and Chief Scientific Officer at Mirati Therapeutics, Inc. She oversees the company's research and development initiatives. Her role is essential for promoting scientific innovation.
